Ultra Health dispensaries in New Mexico have teamed up with Panaxia Pharmaceutical Industries, a company located in Israel. The companies developed marijuana suppositories. They’ve created options for both vaginal and rectal applications.
The companies have also created measured THC and CBD dosed products, according to Albuquerque Journal. The other products created include lozenges, tablets, oils, topicals and patches. A 3,600-sqft production facility has been setup on Ultra Health’s property in Bernalillo.
Panaxia will oversee operations of the new product. Dadi Segal is the CEO of Panaxia and he said his goal is to “apply good manufacturing practices in the pharmaceutical industry to cannabis.” He says this method makes products more useful to both doctors and patients.
Segal said, “Our idea is to offer products to those patients who will not try the benefits of cannabis because they can’t use it like any other medication.”
Once production ramps up, Ultra Health has plans to manufacture 20 of Panaxia’s products that will all contain either THC or CBD. The doses will all be specific.
In Israel, having exact dosage medical marijuana products available has opened up the door to more clinical trials being conducted. The findings of those studies will benefit the U.S. medical marijuana and recreational marijuana industries in a more effective way, showing that marijuana is an effective medicine.
Segal said, “You can’t do clinical trials unless you have measurable doses. Marijuana can never be a medication if you have to smoke it.”
Ultra Health, according to its director of operations Leonard Salgado, invested $1.7-million into this new facility. The facility will create up to a dozen new jobs.
To make this project possible, three years of discussions took place. Ultra Health offers all available Panaxia products at all of its eight dispensaries across the state. Product prices range from $20 to $70.
Salgado said, “I think what the medical community is looking for is a product that is consistent, that has a measured dose, and that actually has the look and feel of a pharmaceutical product.”